RLMD
Relmada Therapeutics Inc
NASDAQ: RLMD · HEALTHCARE · BIOTECHNOLOGY
$7.52
+2.04% today
Updated 2026-04-30
Market cap
$759.40M
P/E ratio
—
P/S ratio
9,001.90x
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$0 – $8
Volume
2.1M
Relmada Therapeutics Inc (RLMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-23.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+53.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+7.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+13.7%
2026-03-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-24 | $-0.29 | -66.8% | $5.86 | $6.66 | +13.7% |
| 2025-11-13 | $-0.30 | +33.3% | $3.91 | $3.95 | +1.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.17 | $-0.29 | -66.8% | — | — |
| 2025-09-30 | $-0.45 | $-0.30 | +33.3% | — | — |
| 2025-06-30 | $-0.40 | $-0.30 | +25.0% | — | — |
| 2025-03-31 | $-0.31 | $-0.58 | -87.1% | — | — |
| 2024-12-31 | $-0.70 | $-0.62 | +11.4% | — | — |
| 2024-09-30 | $-0.64 | $-0.72 | -12.5% | — | — |
| 2024-06-30 | $-0.83 | $-0.59 | +28.9% | — | — |
| 2024-03-31 | $-0.85 | $-0.72 | +15.3% | — | — |
| 2023-12-31 | $-0.83 | $-0.84 | -1.2% | — | — |
| 2023-09-30 | $-0.91 | $-0.73 | +19.8% | — | — |
| 2023-06-30 | $-0.90 | $-0.84 | +6.7% | — | — |
| 2023-03-31 | $-0.89 | $-0.87 | +2.2% | — | — |
Frequently asked questions
Has Relmada Therapeutics Inc beaten earnings estimates?
Relmada Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -23.9% over the last 4 quarters.
How does RLMD stock react to earnings?
RLMD stock has moved an average of +7.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.